Treatment of neurocysticercosis: is praziquantel the new hope?
Moodley
M
M
Department of Paediatrics and Child Health, Faculty of Medicine, University of Natal, Congella, South Africa.
Moosa
A
A
D001927:Brain Diseases / Q000188:drug therapy*; D003551:Cysticercosis / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D006801:Humans; D011223:Praziquantel / Q000009:adverse effects / Q000627:therapeutic use*
D011223:Praziquantel